An investigation looks at Rebion’s blinq device and examines its accuracy in screening for amblyopia and strabismus.
Amblyopia is a common vision problem in children, affecting 2 to 3 out of 100, and went caught early can often be corrected. An investigation examined the accuracy of blinq pediatric vision scanner from Rebion on accuracy when diagnosing amblyopia and strabismus.1
The investigators performed a cross-sectional diagnostic accuracy study. Participants aged 1 to 20 years were enrolled and test by people who were masked to the diagnosis. They were then given a complete ophthalmologic examination by a pediatric ophthalmologist who was masked from the screening result. Separate analyses were used for participants who had been previous treated amblyopia or strabismus.
A total of 193 participants were included in the analysis, with 53 who had been previously treated and 140 who were treatment-naïve. Among the participants who were treatment-naïve, 65 had either amblyopia or strabismus; 11 had risk factors/suspected binocular vision deficit without amblyopia or strabismus; and the other 64 were control. Investigators found that sensitivity was 100%, as all 66 patients who had ocular disease that warranted a referral were given one. The 5 patients who had intermittent strabismus and were given pass results were considered an “acceptable pass” due to patient risk factors and amblyogenic potential. Seven incorrect referrals meant the specificity of 91%. Following an analysis of a subcohort of children aged 2 to 8 years, investigators found similar results (sensitivity 100%; specificity 89%).
The investigators concluded that the device had high sensitivity and specificity when it came to detecting referral-warranted unilateral amblyopia and strabismus. Using the device with vision screening programs could potentially lead to improve disease detection rates along with a reduction in false referrals. In a press release for the study results, Justin Shaka, CEO of Rebion said, "the blinq vision scanner is a powerful tool in the fight to eliminate vision loss from amblyopia and strabismus. By placing our technology in the hands of every pediatric practice and every preschool vision screening program in the country, blinq enables front-line screeners to prioritize those most in need for specialist care."2
References
1. Bosque L, Yamarino C, Salcedo N, et al. Evaluation of the blinq vision scanner for detection of amblyopia and strabismus. Journal of American Association for Pediatric Ophthalmology and Strabismus. 2021;25(4):214.e1-214.e7. doi:10.1016/j.jaapos.2021.02.011
2. Rebion. Newly published clinical trial shows unprecedented accuracy of Rebion's blinq® vision scanner in pediatric vision screening. Published September 20, 2021. Accessed September 24, 2021. https://www.newswire.com/news/newly-published-clinical-trial-shows-unprecedented-accuracy-of-rebions-21501292
Fluoxetine helps refractory nocturnal enuresis but not for long
March 29th 2023A 12-week study in Egypt of the efficacy of fluoxetine (a selective serotonin reuptake inhibitor) in children with treatment-refractory nocturnal enuresis (NE) found that though the treatment achieved a good initial response, it was not sustainable.
Meet the Board: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI
May 20th 2022Contemporary Pediatrics sat down with one of our newest editorial advisory board members: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI to discuss what led to her career in medicine and what she thinks the future holds for pediatrics.
Are some patients predisposed to avascular necrosis after hip surgery?
March 14th 2023Although avascular necrosis (AVN) is believed to be an iatrogenic complication following treatment of developmental dysplasia of the hip, an investigation in China found 2 characteristics associated with the condition: the likelihood of AVN increases with both the grade of dislocation and of underdevelopment of the ossific nucleus.
Meet the board: Jessica L. Peck, DNP, APRN, CPNP-PC, CNE, CNL, FAANP, FAAN
April 22nd 2022In the latest episode of our podcast series, Jessica L. Peck, DNP, APRN, CPNP-PC, CNE, CNL, FAANP, FAAN shares why she got into medicine, the myths of pediatric, and what the future may hold for the specialty.